| Autor: |
Bergerot, Cristiane Decat, Philip, Errol J., Malhotra, Jasnoor, Bergerot, Paulo Gustavo, Castro, Daniela V., Govindarajan, Ameish, Salgia, Sabrina, Salgia, Meghan, Salgia, Nicholas, Hsu, JoAnn, Meza, Luis, Zengin, Zeynep B., Liu, Sandy, Chehrazi‐Raffle, Alex, Tripathi, Abhishek, Dorff, Tanya, Pal, Sumanta |
| Zdroj: |
Journal of Genetic Counseling; Aug2024, Vol. 33 Issue 4, p911-915, 5p |
| Abstrakt: |
We sought to determine racial and ethnic differences in perceptions (quality of communication, expectations, and concerns) of germline or somatic DNA sequencing (genomic profiling). Patients with prostate, urothelial, or kidney cancer were surveyed using a questionnaire that assessed previous experience, beliefs, expectations, and concerns regarding genomic profiling. Descriptive statistics and chi‐square tests were used to identify factors associated with patients' perceptions of genomic profiling. A total of 150 consecutive patients were enrolled. The majority were male (74%) with a mean age of 68 years old. Most patients underwent somatic testing (54%), 24% undertook germline testing, and 21% undertook both tests. Significant differences were found across racial and/or ethnicity concerning factors that could have influenced patients' decision to pursue genomic profiling, including ability to guide the type of treatment (White: 54.1% vs. other ethnic groups: 43.9%, p = 0.04) and potential to improve treatment response (White: 10.1% vs. other ethnic groups: 22.0%, p = 0.04). Other ethnic group of patients were more concerned about learning that the cancer was less treatable or aggressive (43.8% vs. 27.7%, p = 0.01) and anxious about what would be learnt from genomic profiling (34.4% vs. 21.3, p = 0.01) as compared to White patients. Our findings reinforce the importance of developing culturally tailored education to help patients participate actively in decisions about genomic profiling. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text